LRCX - Lam Research Corp Stock Price, Fair Value and News

908.03USD-5.25 (-0.57%)Delayed as of 09 May 2024, 02:25 pm ET

Market Summary

USD908.03-5.25

Delayedas of 09 May 2024, 02:25 pm

-0.57%

LRCX Alerts

3 major insider sales recently.

LRCX Stock Price

View Fullscreen

LRCX RSI Chart

LRCX Valuation

Market Cap

119.4B

Price/Earnings (Trailing)

33.07

Price/Sales (Trailing)

8.38

EV/EBITDA

26.01

Price/Free Cashflow

24.31

LRCX Price/Sales (Trailing)

LRCX Profitability

Operating Margin

86.76%

EBT Margin

28.58%

Return on Equity

45%

Return on Assets

19.75%

Free Cashflow Yield

4.11%

LRCX Fundamentals

LRCX Revenue

Revenue (TTM)

14.2B

Rev. Growth (Yr)

-1.96%

Rev. Growth (Qtr)

0.94%

LRCX Earnings

Earnings (TTM)

3.6B

Earnings Growth (Yr)

18.65%

Earnings Growth (Qtr)

1.21%

Breaking Down LRCX Revenue

52 Week Range

520.66914.42

(Low)(High)

Last 7 days

5.2%

Last 30 days

-5.6%

Last 90 days

5.7%

Trailing 12 Months

77.1%

How does LRCX drawdown profile look like?

LRCX Financial Health

Current Ratio

2.82

Debt/Equity

0.56

Debt/Cashflow

1.1

LRCX Investor Care

Dividend Yield

0.85%

Dividend/Share (TTM)

7.73

Buy Backs (1Y)

2.68%

Diluted EPS (TTM)

27.25

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	14.2B	0	0	0
2023	18.9B	17.4B	15.8B	14.3B
2022	16.7B	17.2B	18.0B	19.0B
2021	13.3B	14.6B	15.8B	16.5B
2020	9.6B	10.0B	11.1B	11.9B
2019	10.4B	9.7B	9.5B	9.5B
2018	10.3B	11.1B	10.9B	10.9B
2017	7.2B	8.0B	8.9B	9.6B
2016	5.8B	5.9B	5.9B	6.4B
2015	5.0B	5.3B	5.7B	5.9B
2014	4.3B	4.6B	4.7B	4.9B
2013	3.4B	3.6B	3.7B	4.0B
2012	2.7B	2.7B	2.9B	3.2B
2011	3.2B	3.2B	3.1B	2.8B
2010	1.9B	2.1B	2.6B	3.0B
2009	0	1.1B	1.4B	1.6B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Lam Research Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 03, 2024	schisler george m	sold	-363,284	908	-400	chief legal officer
Apr 29, 2024	lord patrick j	sold	-55,292	921	-60.00	executive vice president
Apr 01, 2024	corrreia christina	sold	-628,903	972	-647	cvp , chief accounting officer
Apr 01, 2024	talwalkar abhijit y	sold	-857,330	972	-882	-
Mar 19, 2024	varadarajan seshasayee	sold	-5,026,940	913	-5,500	senior vice president
Mar 18, 2024	varadarajan seshasayee	sold	-5,073,260	922	-5,500	senior vice president
Mar 11, 2024	lord patrick j	sold	-3,202,740	927	-3,452	executive vice president
Mar 11, 2024	lord patrick j	sold	-4,449,270	927	-4,795	executive vice president
Mar 11, 2024	lord patrick j	acquired	2,601,500	542	4,795	executive vice president
Mar 01, 2024	corrreia christina	acquired	-	-	570	cvp , chief accounting officer

Which funds bought or sold LRCX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	Keudell/Morrison Wealth Management	reduced	-0.27	406,946	2,123,850	0.64%
May 07, 2024	Malaga Cove Capital, LLC	reduced	-2.84	700,934	4,117,510	1.68%
May 07, 2024	Illinois Municipal Retirement Fund	reduced	-17.31	366,000	14,609,000	0.22%
May 07, 2024	Nelson Capital Management, LLC	new	-	437,207	437,207	0.08%
May 07, 2024	Swiss National Bank	reduced	-4.55	59,600,700	383,479,000	0.27%
May 07, 2024	CHILTON CAPITAL MANAGEMENT LLC	reduced	-0.87	102,856	550,881	0.03%
May 07, 2024	Horizon Investment Services, LLC	reduced	-4.14	1,366,580	8,596,010	4.21%
May 07, 2024	Hansen & Associates Financial Group, Inc.	new	-	269,166	269,166	0.15%
May 07, 2024	Qsemble Capital Management, LP	sold off	-100	-371,265	-	-%
May 07, 2024	Strategic Financial Services, Inc,	reduced	-8.01	550,316	4,451,730	0.29%

Are Funds Buying or Selling LRCX?

Are funds buying LRCX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own LRCX

No. of Funds

LRCX Alerts

3 major insider sales recently.

Unveiling Lam Research Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	8.89%	11,711,468	SC 13G/A
Jan 25, 2024	blackrock inc.	8.9%	11,777,978	SC 13G/A
Feb 09, 2023	vanguard group inc	8.64%	11,788,267	SC 13G/A
Feb 03, 2023	blackrock inc.	8.1%	11,026,970	SC 13G/A
Feb 10, 2022	vanguard group inc	8.17%	11,504,998	SC 13G/A
Feb 09, 2022	fmr llc	-	0	SC 13G/A
Feb 01, 2022	blackrock inc.	7.9%	11,100,869	SC 13G/A
Feb 12, 2021	ameriprise financial inc	3.67%	5,285,039	SC 13G/A
Feb 10, 2021	vanguard group inc	8.08%	11,640,096	SC 13G/A
Feb 08, 2021	fmr llc	-	0	SC 13G/A

Recent SEC filings of Lam Research Corp

View All Filings

Date Filed	Form Type	Document
May 06, 2024	4	Insider Trading
May 03, 2024	144	Notice of Insider Sale Intent
Apr 30, 2024	4	Insider Trading
Apr 29, 2024	10-Q	Quarterly Report
Apr 29, 2024	144	Notice of Insider Sale Intent
Apr 24, 2024	8-K	Current Report
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 01, 2024	144	Notice of Insider Sale Intent
Apr 01, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Lam Research Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
NVDA	2.3T	60.9B	3.65%	216.11%	75.87	37.06	125.85%	581.31%
AMD	248.3B	22.8B	-9.57%	61.62%	222.52	10.89	-1.16%	182.53%
AMAT	172.3B	26.5B	-0.79%	82.18%	24.08	6.51	0.88%	10.98%
INTC	127.7B	55.2B	-21.01%	-0.33%	31.41	2.31	-2.09%	242.32%
ADI	101.6B	11.6B	4.15%	14.05%	36.08	8.78	-8.03%	-17.90%
MID-CAP
AMKR	8.0B	6.4B	3.77%	51.47%	21.45	1.25	-8.17%	-41.71%
CRUS	5.5B	1.8B	11.66%	32.77%	31.32	3.08	-11.16%	-46.12%
ACLS	3.6B	1.1B	6.44%	-7.04%	14.49	3.21	16.34%	32.25%
DIOD	3.4B	1.7B	7.34%	-9.83%	15.08	2.06	-16.94%	-31.42%
AMBA	1.9B	226.5M	-4.44%	-29.63%	-11.18	8.37	-32.92%	-159.10%
SMALL-CAP
ACMR	1.6B	635.7M	-18.15%	156.84%	17.9	2.47	51.02%	67.91%
AOSL	772.9M	657.5M	17.44%	14.84%	-81.77	1.18	-9.15%	-119.91%
AEHR	325.3M	71.9M	-3.27%	-59.79%	21.12	4.53	14.14%	8.17%
ATOM	112.9M	550.0K	-30.69%	-52.81%	-5.76	205.32	43.98%	-6.63%
ASYS	70.5M	108.8M	1.02%	-44.89%	-3.29	0.65	1.54%	-244.16%

Lam Research Corp News

Latest updates

Lam Research Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	0.9%	3,794	3,758	3,482	3,207	3,870	5,278	5,074	4,636	4,060	4,227	4,304	4,145	3,848	3,456	3,177	2,792	2,504	2,584	2,166	2,361	2,439
Gross Profit	2.5%	1,801	1,757	1,655	1,458	1,606	2,376	2,337	2,101	1,817	1,978	1,977	1,915	1,780	1,604	1,506	1,280	1,167	1,180	982	1,081	1,074
Operating Expenses	6.2%	743	700	632	604	663	696	639	621	625	640	605	599	585	594	545	525	473	493	444	464	509
S&GA Expenses	-5.7%	216	229	207	200	194	234	206	210	217	236	222	218	204	219	190	186	165	174	157	168	190
R&D Expenses	9.1%	512	470	423	402	429	462	433	411	407	404	382	382	381	375	355	339	308	319	287	296	319
EBITDA Margin	4.0%	0.32*	0.31*	0.32*	0.32*	0.32*	0.33*	0.33*	0.33*	0.34*	0.34*	0.34*	0.33*	-	-	-	-	-	-	-	-	-
Interest Expenses	-	47.00	-	-	35.00	47.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Taxes	-4.1%	127	133	138	61.00	125	183	229	150	113	161	164	164	89.00	111	99.00	52.00	55.00	158	59.00	68.00	39.00
Earnings Before Taxes	0.6%	1,093	1,087	1,026	864	939	1,652	1,655	1,359	1,135	1,356	1,343	1,309	1,160	980	922	748	629	673	525	609	586
EBT Margin	4.5%	0.29*	0.27*	0.28*	0.29*	0.30*	0.30*	0.31*	0.30*	0.31*	0.31*	0.30*	0.30*	-	-	-	-	-	-	-	-	-
Net Income	1.2%	966	954	887	803	814	1,469	1,426	1,209	1,022	1,195	1,180	1,145	1,071	869	823	697	575	515	466	542	547
Net Income Margin	4.9%	0.25*	0.24*	0.25*	0.26*	0.26*	0.27*	0.27*	0.27*	0.27*	0.28*	0.27*	0.27*	-	-	-	-	-	-	-	-	-
Free Cashflow	-4.7%	1,385	1,454	951	1,123	1,726	1,140	1,190	444	758	1,441	458	1,436	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-2.7%	18,280	18,784	18,538	18,782	19,243	19,206	18,721	17,196	16,589	16,685	15,566	15,892	15,285	15,370	15,057	14,559	12,939	11,914	12,344	12,001	12,895
Current Assets	-4.3%	12,488	13,055	12,994	13,228	13,730	13,709	13,613	12,285	11,888	12,103	11,145	11,652	11,322	11,468	11,275	10,854	9,409	8,455	8,835	8,560	9,442
Cash Equivalents	0.9%	5,672	5,623	5,126	5,337	5,306	4,485	4,256	3,774	4,195	5,087	4,042	4,418	3,673	3,687	4,129	5,169	3,962	3,036	4,607	3,913	4,932
Inventory	-2.4%	4,323	4,430	4,748	4,816	4,882	4,820	4,360	3,966	3,479	3,074	2,872	2,689	2,552	2,349	2,138	1,900	1,675	1,529	1,483	1,540	1,622
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,030	1,059	1,040
Goodwill	-1.6%	1,600	1,627	1,600	1,622	1,622	1,620	1,500	1,515	1,514	1,500	1,500	1,490	1,490	1,485	1,500	1,484	1,484	1,500	1,500	1,485	1,500
Liabilities	-2.9%	10,258	10,561	10,491	10,571	10,836	10,902	11,309	10,917	10,563	10,210	9,746	9,865	9,910	9,862	9,632	9,376	8,389	7,496	7,365	7,278	7,554
Current Liabilities	3.7%	4,430	4,272	4,247	4,185	4,441	4,547	5,053	4,565	4,195	3,863	3,409	3,528	3,612	3,591	3,407	3,162	2,106	2,566	2,458	2,372	2,806
Long Term Debt	-10.1%	4,478	4,980	4,980	5,003	4,997	4,996	4,996	4,998	5,001	4,988	4,989	4,990	4,992	4,992	4,993	4,971	5,044	3,786	3,788	3,823	3,802
Shareholder's Equity	-2.4%	8,022	8,222	8,047	8,210	8,407	8,305	7,413	6,278	6,026	6,476	5,820	6,027	5,372	5,503	5,419	5,172	4,538	4,379	4,936	4,674	5,291
Retained Earnings	3.0%	24,052	23,347	22,655	22,032	21,460	20,879	19,645	18,455	17,451	16,638	15,653	14,685	13,726	12,840	12,157	11,521	10,991	10,584	10,233	9,931	9,548
Additional Paid-In Capital	1.1%	8,082	7,997	7,879	7,809	7,680	7,606	7,493	7,415	7,289	7,220	7,112	7,053	6,922	6,855	6,762	6,696	6,578	6,529	6,456	6,409	6,315
Shares Outstanding	-0.4%	131	131	132	133	135	136	137	137	139	141	142	144	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	46,244	-	-	-	77,032	-	-	-	53,314	-	-	-	29,587	-	-	-

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-4.7%	1,385	1,454	951	1,123	1,726	1,140	1,190	444	758	1,441	458	1,436	1,165	345	643	813	541	308	464	880	933
Share Based Compensation	9.9%	77.00	70.00	67.00	68.00	74.00	73.00	71.00	70.00	69.00	63.00	58.00	56.00	56.00	52.00	56.00	53.00	47.00	46.00	43.00	45.00	53.00
Cashflow From Investing	9.4%	-92.36	-101	-74.68	-55.18	-84.33	-267	-127	-75.94	-94.56	186	597	689	116	70.00	-801	-430	170	-734	751	-623	-1,008
Cashflow From Financing	-43.7%	-1,235	-859	-1,326	-1,037	-819	-662	-310	-1,023	-1,549	-578	-1,427	-1,381	-1,288	-865	-631	563	225	-1,150	-262	-1,527	1,644
Dividend Payments	-0.6%	263	264	230	232	234	236	206	208	211	211	185	185	187	188	167	168	164	167	159	165	171
Buy Backs	51.9%	981	645	843	869	582	456	110	876	1,338	415	1,237	431	1,095	723	449	41.00	245	1,005	78.00	1,109	935

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

LRCX Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 26, 2023	Mar. 31, 2024	Mar. 26, 2023
Income Statement [Abstract]
Revenue	$ 3,793,558	$ 3,869,569	$ 11,033,879	$ 14,221,259
Cost of goods sold	1,977,820	2,197,237	5,783,087	7,835,743
Restructuring charges, net - cost of goods sold	15,202	66,720	38,099	66,720
Total cost of goods sold	1,993,022	2,263,957	5,821,186	7,902,463
Gross margin	1,800,536	1,605,612	5,212,693	6,318,796
Research and development	512,274	429,451	1,404,615	1,325,211
Selling, general, and administrative	215,904	193,500	651,770	632,922
Restructuring charges, net - operating expenses	15,246	40,408	18,955	40,408
Total operating expenses	743,424	663,359	2,075,340	1,998,541
Operating income	1,057,112	942,253	3,137,353	4,320,255
Other income (expense), net	36,073	(3,331)	68,513	(74,660)
Income before income taxes	1,093,185	938,922	3,205,866	4,245,595
Income tax expense	(127,359)	(124,914)	(398,376)	(537,201)
Net income	$ 965,826	$ 814,008	$ 2,807,490	$ 3,708,394
Net income per share:
Basic (in dollars per share)	$ 7.38	$ 6.03	$ 21.32	$ 27.28
Diluted (in dollars per share)	$ 7.34	$ 6.01	$ 21.22	$ 27.20
Number of shares used in per share calculations:
Basic (in shares)	130,838	134,924	131,663	135,945
Diluted (in shares)	131,518	135,395	132,282	136,314

LRCX Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands

Mar. 31, 2024

Jun. 25, 2023

^[1]

ASSETS

Cash and cash equivalents

$ 5,672,232

$ 5,337,056

Investments

37,641

Accounts receivable, less allowance of $5,286 as of March 31, 2024, and $5,344 as of June 25, 2023

2,203,707

2,823,376

Inventories

4,322,967

4,816,190

Prepaid expenses and other current assets

289,530

214,149

Total current assets

12,488,436

13,228,412

Property and equipment, net

2,181,741

1,856,672

Goodwill

1,626,519

1,622,489

Intangible assets, net

142,479

168,454

Other assets

1,840,475

1,905,616

Total assets

18,279,650

18,781,643

LIABILITIES AND STOCKHOLDERS’ EQUITY

Trade accounts payable

531,648

470,702

Accrued expenses and other current liabilities

1,791,642

2,010,637

Deferred profit

1,601,733

1,695,221

Current portion of long-term debt and finance lease obligations

505,066

8,358

Total current liabilities

4,430,089

4,184,918

Long-term debt and finance lease obligations, less current portion

4,478,385

5,003,183

Income taxes payable

832,397

882,084

Other long-term liabilities

516,678

501,286

Total liabilities

10,257,549

10,571,471

Commitments and contingencies (refer to Note 13)

Stockholders’ equity:

Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding

Common stock, at par value of $0.001 per share; authorized, 400,000 shares as of March 31, 2024 and June 25, 2023; issued and outstanding, 130,736 shares as of March 31, 2024, and 133,297 shares as of June 25, 2023

131

133

Additional paid-in capital

8,082,339

7,809,002

Treasury stock, at cost; 164,423 shares as of March 31, 2024, and 161,380 shares as of June 25, 2023

(23,984,518)

(21,530,353)

Accumulated other comprehensive loss

(127,788)

(100,706)

Retained earnings

24,051,937

22,032,096

Total stockholders’ equity

8,022,101

8,210,172

Total liabilities and stockholders’ equity

$ 18,279,650

$ 18,781,643

[1]	Derived from audited financial statements

About Lam Research Corp

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. The company was incorporated in 1980 and is headquartered in Fremont, California.

CEO	Mr. Timothy M. Archer
WEBSITE	lamresearch.com
INDUSTRY	Semiconductors
EMPLOYEES	17200

Lam Research Corp Frequently Asked Questions

What is the ticker symbol for Lam Research Corp? What does LRCX stand for in stocks?

LRCX is the stock ticker symbol of Lam Research Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lam Research Corp (LRCX)?

As of Wed May 08 2024, market cap of Lam Research Corp is 119.4 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LRCX stock?

You can check LRCX's fair value in chart for subscribers.

What is the fair value of LRCX stock?

You can check LRCX's fair value in chart for subscribers. The fair value of Lam Research Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Lam Research Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LRCX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Lam Research Corp a good stock to buy?

The fair value guage provides a quick view whether LRCX is over valued or under valued. Whether Lam Research Corp is cheap or expensive depends on the assumptions which impact Lam Research Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LRCX.

What is Lam Research Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, LRCX's PE ratio (Price to Earnings) is 33.07 and Price to Sales (PS) ratio is 8.38. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LRCX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Lam Research Corp's stock?

In the past 10 years, Lam Research Corp has provided 0.336 (multiply by 100 for percentage) rate of return.